​The global structural heart devices market is experiencing significant growth, driven by the increasing prevalence of structural heart diseases, advancements in minimally invasive procedures, and a growing geriatric population. According to a report by Fact.MR, the market is projected to expand from a valuation of US$12.17 billion in 2023 to US$36.06 billion by 2033, reflecting a compound annual growth rate (CAGR) of 11%. ​

Market Development

Several factors contribute to the robust development of the structural heart devices market. The rising incidence of cardiovascular conditions, such as aortic stenosis and mitral regurgitation, has led to an increased demand for effective treatment options. Additionally, technological advancements have facilitated the shift from traditional open-heart surgeries to minimally invasive procedures like transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR). These procedures offer reduced recovery times and lower risks, making them preferable for both patients and healthcare providers. Furthermore, the growing awareness and early diagnosis of structural heart diseases have amplified the need for advanced therapeutic solutions

Market Outlook

The future of the structural heart devices market appears promising, with sustained growth anticipated over the next decade. The increasing adoption of minimally invasive procedures is expected to continue, driven by patient preference and clinical benefits. Moreover, ongoing research and development efforts are likely to yield innovative products that enhance the efficacy and safety of structural heart interventions. However, challenges such as the high cost of devices and procedures, along with stringent regulatory requirements, may pose constraints to market expansion.

Market Analysis

A detailed analysis reveals that heart valve devices constitute a significant segment within the structural heart devices market. The demand for these devices is projected to rise at a CAGR of 11.5% from 2023 to 2033. This growth is attributed to the increasing prevalence of heart valve diseases and the preference for minimally invasive treatment options. Additionally, the development of tissue-engineered heart valves (TEHV) offers new therapeutic possibilities for patients requiring valve replacement. ​

Overview and Scope of the Report

The Fact.MR report provides a comprehensive analysis of the global structural heart devices market, covering over 30 countries, including the United States, Canada, the United Kingdom, Germany, France, Nordic countries, GCC countries, Japan, and South Korea. It examines various market segments, identifies key players, and offers insights into market dynamics, trends, and future projections. The report serves as a valuable resource for stakeholders seeking to understand the current landscape and future outlook of the structural heart devices market.

Market Segmentation

The market is segmented based on product type, procedure, age group, indication, and end user.​

• By Product: Heart valve devices, surgical heart valves, transcatheter heart valves, occluders and delivery systems.​
• By Procedure: Replacement procedures, repair procedures.​
• By Age Group: Pediatrics, adults, geriatrics.​
• By Indication: Atrial septal defect (ASD), ventricular septal defect (VSD), patent foramen ovale (PFO), aortic valve stenosis.​
• By End User: Hospitals, ambulatory surgical centers, cardiac centers.​

This segmentation allows for a nuanced understanding of the market, facilitating targeted strategies for different segments. ​

Key Players Covered in This Report

The report profiles several key players in the structural heart devices market, including:​

• Abbott Laboratories, Inc.​
• Boston Scientific Corporation​
• Braile Biomedica​
• CryoLife, Inc
• Edwards Lifesciences Corporation
• Lepu Medical Technology (Beijing) Co., Ltd
• LivaNova PLC​
• Medtronic PLC
• Micro Interventional Devices, Inc.​
• TTK Healthcare Ltd.​

These companies are recognized for their contributions to the market through innovative products and strategic initiatives. ​

Competitive Landscape

The structural heart devices market is characterized by intense competition among established players and emerging companies. Key strategies employed by these companies include product innovation, strategic partnerships, and mergers and acquisitions to enhance their market presence. For instance, in November 2019, Edwards Lifesciences received the CE mark for its Edwards SAPIEN 3 valve, expanding its use in treating aortic stenosis patients at lower risk for open-heart surgeries

Highlights of Our Report

The Fact.MR report offers several key highlights:​

• Detailed market segmentation and analysis.​
• Insights into market drivers, restraints, and opportunities.​
• Profiles of key market players and their strategies.​
• Regional analysis covering major markets worldwide.​
• Future outlook and market projections up to 2033.​

These highlights provide a comprehensive understanding of the market dynamics and assist stakeholders in making informed decisions. ​

Read More-

Sales of recycling machines in Europe are estimated at US$ 878.6 million in 2024 and are forecasted to advance at a CAGR of 5.3% to reach US$ 1.47 billion by the end of 2034.

The long range drone market was valued at USD 8,187 Million in 2024 and has been forecasted to expand at a noteworthy CAGR of 18.3% to end up at USD 53,020 Million by 2035.

The global automotive wheel market has been studied by Fact.MR and is forecasted to reach US$ 34.42 billion in 2024, further increasing at a CAGR of 6.4% to end up at US$ 63.95 billion by 2034.

The global termite bait products market is valued to be US$ 1.3 billion in 2023 and it is anticipated to grow at a CAGR of 4.9% to reach US$ 2.1 billion by the end of 2033.

The global offshore drone inspection market is expected to reach a valuation of US$ 421.6 million in 2023 and is expected to progress at a CAGR of 13% to reach US$ 1,456.8 million by the end of 2033.

The global nerve monitoring devices market was valued at US$ 1.3 Billion in 2021, and is projected to register a Y-o-Y increase of 5.6% in 2022 to be valued at US$ 1.4 Billion.